Latest California Healthline Stories
Gobernador de California firma larga lista de leyes de salud que revelan los problemas de 2020
El Gobernador Gavin Newsom terminó su maratón de firmas, poniendo fin a una sesión legislativa que tendrá un impacto enorme en la atención de salud y la cobertura de los californianos.
How Newsom’s Bill-Signing Marathon Affects Your Health Care
California Gov. Gavin Newsom signed off on an array of health care bills that will significantly affect the lives of Californians, including many college students, pregnant women, schoolchildren and dialysis patients.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
California’s New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California’s first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
As Medicare Enrollment Nears, Popular Price Comparison Tool Missing Key Details
For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.
KHN’s ‘What The Health?’: Impeachment And The Health Agenda
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients’ Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
KHN’s ‘What The Health?’: Tennessee Seeks Medicaid Changes
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book “The Price We Pay” about why health care costs so much.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.